XML 65 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Compensation Plans (Stock Appreciation Rights) (Details) - Stock Appreciation Rights (SARs) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Number of shares outstanding at beginning of period 1,183,024  
Number of shares granted 0 1,400,000
Number of shares exercised (916,874)  
Number of shares canceled and expired 0  
Number of shares outstanding at end of period 266,150  
Number of shares vested and expected to vest 266,150  
Number of shares exercisable 266,150,000  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]    
Weighted average exercise price outstanding at beginning of period $ 3.53  
Weighted average exercise price granted 0.00  
Weighted average exercise price exercised 3.53  
Weighted average exercise price canceled and expired 0.00  
Weighted average exercise price outstanding at end of period 3.53  
Weighted average exercise price, vested and expected to vest 3.53  
Weighted average exercise price, exercisable $ 3.53  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]    
Weighted average remaining life, outstanding 1 year 1 month 2 days  
Weighted average remaining life, vested and expected to vest 1 year 1 month 2 days  
Weighted average remaining life, exercisable 1 year 1 month 2 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]    
Intrinsic value outstanding $ 0  
Intrinsic value, vested and expected to vest $ 0  
Intrinsic value, exercisable $ 0